2002

October 23, 2002
Panacea Pharmaceuticals, Inc. Awarded SBIR Grant from National Cancer Institute to Develop Diagnostic Test for Pancreatic Cancer

October 18, 2002
Panacea Pharmaceuticals, Inc. Presents at 3rd World Knowledge Forum in Seoul, South Korea

August 29, 2002
Panacea Pharmaceuticals, Inc. Announces Important New Publications Supporting HAAH Oncology Program

July 24, 2002
Panacea Pharmaceuticals, Inc. Presents New Findings At 8th International Conference on Alzheimer's Disease and Related Disorders

June 27, 2002
Panacea Pharmaceuticals, Inc. Announces Collaboration with Rhode Island Hospital/Brown University to Treat Oxidative Stress Induced Conditions Including Alzheimer's Disease

June 18, 2002
Panacea Pharmaceuticals, Inc. Named 2002 Maryland Incubator Company of the Year

June 6, 2002
Panacea Pharmaceuticals, Inc. Announces Appointment of Dean P. Lewis as Chief Financial Officer

May 21, 2002
Panacea Pharmaceuticals, Inc. Awarded SBIR Grant for Cancer Drug Development

April 14, 2002
Panacea Pharmaceuticals, Inc. and MedImmune, Inc. Sign Collaboration and License Agreement to Discover, Develop, and Commercialize Cancer Therapeutics

January 8, 2002
Panacea Pharmaceuticals, Inc. Announces Addition of James K. V. Willson, MD To Clinical Advisory Board

January 2, 2002
Panacea Pharmaceuticals, Inc. Appoints Former FDA Commissioner Frank E. Young to Board of Directors